glp-1 agonist in esrd Frontiers The potential of GLP-1 receptor
Description
10.1056/NEJMoa1305889 63
Semaglutide shows slower but more sustainable resultsstudies show consistent reduction over several months, with long-term maintenance possible through ongoing treatment and support
Comparative Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists With Regard to 6-Month Glycaemic Control and Weight Outcomes in Patients With Type 2 Diabetes
Tuttle KR, Bakris GL, Bilous RW, et al
Hypoglycemia should be avoided when using insulin or sulfonylureas together with insulin-secreting agents
